Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 4
2007 4
2008 9
2009 3
2010 4
2011 13
2012 14
2013 8
2014 12
2015 9
2016 10
2017 10
2018 9
2019 13
2020 9
2021 7
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Katz MHG, Petroni GR, Bauer T, Reilley MJ, Wolpin BM, Stucky CC, Bekaii-Saab TS, Elias R, Merchant N, Dias Costa A, Lenehan P, Cardot-Ruffino V, Rodig S, Pfaff K, Dougan SK, Nowak JA, Varadhachary GR, Slingluff CL, Rahma O. Katz MHG, et al. Among authors: varadhachary gr. J Immunother Cancer. 2023 Dec 1;11(12):e007586. doi: 10.1136/jitc-2023-007586. J Immunother Cancer. 2023. PMID: 38040420 Free PMC article. Clinical Trial.
Cancer of unknown primary site.
Varadhachary GR, Raber MN. Varadhachary GR, et al. N Engl J Med. 2014 Aug 21;371(8):757-65. doi: 10.1056/NEJMra1303917. N Engl J Med. 2014. PMID: 25140961 Review. No abstract available.
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
Huey RW, Shah AT, Reddi HV, Dasari P, Topham JT, Hwang H, Dhillon N, Willett A, Smaglo BG, Estrella JS, Rashid A, Matamoros A, Overman MJ, Choquette L, Omerza G, Kelly K, Wang X, Loree JM, Rueter J, Varadhachary GR, Raghav K. Huey RW, et al. Among authors: varadhachary gr. J Natl Cancer Inst. 2023 Aug 8;115(8):994-997. doi: 10.1093/jnci/djad095. J Natl Cancer Inst. 2023. PMID: 37202363 Clinical Trial.
Carcinoma of unknown primary: focused evaluation.
Varadhachary GR. Varadhachary GR. J Natl Compr Canc Netw. 2011 Dec;9(12):1406-12. doi: 10.6004/jnccn.2011.0119. J Natl Compr Canc Netw. 2011. PMID: 22157558 Review.
Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Tamm EP, et al. Among authors: varadhachary gr. Radiol Clin North Am. 2012 May;50(3):407-28. doi: 10.1016/j.rcl.2012.03.008. Epub 2012 Apr 6. Radiol Clin North Am. 2012. PMID: 22560689 Review.
Diagnostic strategies for unknown primary cancer.
Varadhachary GR, Abbruzzese JL, Lenzi R. Varadhachary GR, et al. Cancer. 2004 May 1;100(9):1776-85. doi: 10.1002/cncr.20202. Cancer. 2004. PMID: 15112256 Free article. Review.
Occult primary, version 3.2014.
Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA; National Comprehensive Cancer Network. Ettinger DS, et al. Among authors: varadhachary gr. J Natl Compr Canc Netw. 2014 Jul;12(7):969-74. doi: 10.6004/jnccn.2014.0093. J Natl Compr Canc Netw. 2014. PMID: 24994917
124 results